Amarin Corp Plc (AMRN)

[Pharmacydude]

Seve
“some judge ruling in other countries will allow generics in and we will be back to a buck again.”

Wrong. In the EU Amarin has REGULATORY EXCLUSIVITY not patent protection (or lack there of). Amarin has a guaranteed market for another 6-7 years (could be extended) and that is a considerable amount of time to sell. Awareness and acceptance of V will grow faster in the EU than it did in the US or Canada because it has a history and Pt years of experience. The questioning of the science (driven and funded by PAYERs) will disappear (with the MITIGATE TRIAL DATA - right Kiwi) when the financial need for doubt disappears.

Yes, we have another year or more to wait but the future is still bright. It is also possible that Pfizer or Novartis (who are very aware of its potential) may jump in early to avoid the competitor getting the drug.